Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
The 4q21 microdeletion syndrome is a newly described syndrome associated with facial dysmorphism, progressive growth restriction, severe intellectual deficit and absent or severely delayed speech.
Features include always present findings: Severe short stature, Long philtrum, Delayed skeletal maturation, and Narrow mouth and others. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Growth and development | 2 | Severe short stature, Postnatal growth retardation |
Phenotype severity distribution: 8 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chromosome 4q21 deletion syndrome.
1 publication has been identified in PubMed for chromosome 4q21 deletion syndrome. Research spans Review / Meta-Analysis (100%).
van de Velde S (2026). [PMID: 41077824](https://pubmed.ncbi.nlm.nih.gov/41077824/). *Clin Genet*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 12:28 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chromosome 4q21 deletion syndrome
2 |
Global developmental delay, Cerebral hypoplasia |
Bones and joints | 1 | Delayed skeletal maturation |
Muscles | 1 | Low muscle tone (hypotonia) |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |